NO20074873L - Lerkanidipinfri base - Google Patents

Lerkanidipinfri base

Info

Publication number
NO20074873L
NO20074873L NO20074873A NO20074873A NO20074873L NO 20074873 L NO20074873 L NO 20074873L NO 20074873 A NO20074873 A NO 20074873A NO 20074873 A NO20074873 A NO 20074873A NO 20074873 L NO20074873 L NO 20074873L
Authority
NO
Norway
Prior art keywords
free base
larchanidipine
approx
lercanidipine free
purity
Prior art date
Application number
NO20074873A
Other languages
English (en)
Norwegian (no)
Inventor
Gianni Motta
Ilaria Candiani
Amedeo Leonardi
Fabio Berlati
Francesco Corcella
Original Assignee
Recordati Ireland Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recordati Ireland Ltd filed Critical Recordati Ireland Ltd
Publication of NO20074873L publication Critical patent/NO20074873L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
  • Pyridine Compounds (AREA)
NO20074873A 2005-02-25 2007-09-25 Lerkanidipinfri base NO20074873L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65674105P 2005-02-25 2005-02-25
PCT/EP2006/001783 WO2006089788A1 (en) 2005-02-25 2006-02-24 Lercanidipine free base

Publications (1)

Publication Number Publication Date
NO20074873L true NO20074873L (no) 2007-11-22

Family

ID=36587241

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20074873A NO20074873L (no) 2005-02-25 2007-09-25 Lerkanidipinfri base

Country Status (18)

Country Link
US (1) US20060199849A1 (zh)
EP (1) EP1853562A1 (zh)
JP (1) JP2008531516A (zh)
KR (1) KR20070105978A (zh)
CN (1) CN101142186A (zh)
AR (1) AR053023A1 (zh)
AU (1) AU2006218027A1 (zh)
BR (1) BRPI0608136A2 (zh)
CA (1) CA2597992A1 (zh)
EA (1) EA200701686A1 (zh)
IL (1) IL184348A0 (zh)
MX (1) MX2007010362A (zh)
NO (1) NO20074873L (zh)
PE (1) PE20061393A1 (zh)
TW (1) TW200640860A (zh)
UY (1) UY29400A1 (zh)
WO (1) WO2006089788A1 (zh)
ZA (1) ZA200708126B (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100651212B1 (ko) * 2004-10-27 2006-12-01 제일약품주식회사 무정형 레르카니디핀의 제조방법
WO2008040367A1 (en) * 2006-08-01 2008-04-10 Union Quimico-Farmaceutica S.A. Lercanidipine hydrobromide, a process for its preparation, crystalline forms and compositions thereof
DE102010005124A1 (de) * 2010-01-19 2012-03-01 Stada Arzneimittel Ag Feste pharmazeutische Zusammensetzung umfassend Lercanidipin
CN102558032B (zh) * 2011-12-16 2014-02-26 华润赛科药业有限责任公司 一种无定形盐酸乐卡地平及其制备方法
CN102531999B (zh) * 2011-12-16 2014-02-26 华润赛科药业有限责任公司 无定形盐酸乐卡地平及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8403866D0 (en) * 1984-02-14 1984-03-21 Recordati Chem Pharm Diphenylalkylaminoalkyl esters
US5696139A (en) * 1995-05-12 1997-12-09 Recordati S.A., Chemical And Pharmaceutical Company Use of S-enantiomers of 1,4-dihydropyridine derivatives for treating heart failure
US5767136A (en) * 1995-05-12 1998-06-16 Recordati, S.A. Chemical And Pharmaceutical Company 1,4-Dihydropyridines useful for prevention or reduction of atherosclerotic lesions on arterial walls
IT1275532B (it) * 1995-07-14 1997-08-07 Recordati Chem Pharm Uso di derivati 1,4-diidropiridinici per la prevenzione e la terapia della degenerazione aterosclerotica della parete arteriosa
IT1298732B1 (it) * 1998-03-13 2000-02-02 Recordati Chem Pharm Composizioni farmaceutiche orali assumibili senza liquidi,contenenti complessi di inclusione
US6852737B2 (en) * 2001-08-06 2005-02-08 Recordati Ireland Limited Crude and crystalline forms of lercanidipine hydrochloride
US20030069285A1 (en) * 2001-08-06 2003-04-10 Recordati Ireland Limited Novel solvate and crystalline forms of lercanidipine hydrochloride
US20030180355A1 (en) * 2001-10-16 2003-09-25 Amedeo Leonardi Combination therapy for hypertension
EP1553941A1 (en) * 2002-10-16 2005-07-20 Recordati Ireland Limited Lisinopril/lercanidipine combination therapy
US20040147566A1 (en) * 2002-10-16 2004-07-29 Amedeo Leonardi Lisinopril/lercanidipine combination therapy
US20040198789A1 (en) * 2003-02-28 2004-10-07 Recordati Ireland Limited Lercanidipine/ARB/diuretic therapeutic combinations
BRPI0417043A (pt) * 2003-12-01 2007-02-06 Lifecycle Pharma As composição farmacêutica, forma de dosagem sólida, método de manufatura de forma de dosagem sólida, e, uso da composição
TW200613275A (en) * 2004-08-24 2006-05-01 Recordati Ireland Ltd Lercanidipine salts
TW200616681A (en) * 2004-10-05 2006-06-01 Recordati Ireland Ltd Lercanidipine capsules

Also Published As

Publication number Publication date
MX2007010362A (es) 2007-10-17
US20060199849A1 (en) 2006-09-07
EA200701686A1 (ru) 2008-02-28
JP2008531516A (ja) 2008-08-14
TW200640860A (en) 2006-12-01
BRPI0608136A2 (pt) 2009-11-17
ZA200708126B (en) 2008-11-26
AR053023A1 (es) 2007-04-18
WO2006089788A1 (en) 2006-08-31
UY29400A1 (es) 2006-06-30
IL184348A0 (en) 2007-10-31
CN101142186A (zh) 2008-03-12
EP1853562A1 (en) 2007-11-14
KR20070105978A (ko) 2007-10-31
CA2597992A1 (en) 2006-08-31
AU2006218027A1 (en) 2006-08-31
PE20061393A1 (es) 2007-01-16

Similar Documents

Publication Publication Date Title
NO20074874L (no) Amorf lerkanidipinhydroklorid
ATE465719T1 (de) Oral zerfallende zusammensetzung von olanzapin oder donepezil
NO20084855L (no) Fremgangsmate for fremstilling av poxvirus og poxvirussammensetninger
NO20074873L (no) Lerkanidipinfri base
CY1117228T1 (el) Διεργασια για την παρασκευη συνθεσεων υδροχλωρικης οξυκωδονης που εχουν λιγοτερο απο 25 ppm 14-υδροξυκωδεϊνονη
NO20074275L (no) 2- (4-okso-4H-kinazolin-3-yl) acetamider og deres anvendelse som Vasopressin-V3-antagonister
NO20080243L (no) Substituerte arylpyrazoler til anvendelse mot parasitter
NO20055568L (no) Substituerte 1,4-diazepiner og anvendelser derav
NO20070489L (no) 3-aminocyklopentankarboksamider som modulatorer av kjemokinreseptorer.
CY1106857T1 (el) Βενζαμιδια 4-(αμινομεθυλ)-πιπεριδινης ως 5ht4-ανταγωνιστες
NO20082174L (no) 3,5-disubstituerte fenylpiperidiner som modulatorer av dopamin-neurotransmisjon
CY1109854T1 (el) Παραγωγα αζαδικυκλο(3.1.0)εξανιου χρησιμα ως ρυθμιστες υποδοχεων d3 ντοπαμινης
DE60224404D1 (de) Substiuierte piperidine als melanocortinrezeptor-modulatoren
NO20076648L (no) Novel thiophene derivatives
WO2003086306A3 (en) 5ht2c receptor modulators
EA200600235A1 (ru) Трёхзамещённые производные арилов и гетероарилов в качестве модуляторов метаболизма и профилактика и лечение связанных с ними нарушений
NO20064579L (no) Bifenylforbindelser anvendelige som muskariniske receptorantagonister
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
NO20064325L (no) Heteroarylaminopyrazolderivativer nyttige for behandling av diabetes
NO20082124L (no) Bifenyloksyeddiksyrederivater for behandling av respiratorisk sykdom
NO20074895L (no) Isoksazolin derivat og ny fremgangsmate for fremstilling derav
NO20072494L (no) Fast farmasoytisk forbindelse som omfatter donepezil-hydroklorid
NO20070206L (no) Sammensetninger inneholdende strontium og vitamin D og anvendelser derav
NO20071372L (no) Nye polymorfer av azabisykloheksan
EA201071183A1 (ru) Безводная кристаллическая форма малеата орвепитанта

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application